What we're about

We gather monthly to discuss compliance challenges related to FDA's 21 CFR Part 11 and similar regulations. Our members come from Pharmaceutical manufacturers, Clinical Research Organizations, Medical Device makers, computer system validation groups, and IT systems consultancies. Discussion topics include quality assurance, data integrity, privacy, legal, technology, data management, and security.

Upcoming events (5+)

Join your Triangle PEERS to discuss all-things 21CFR Part 11

Quintiles IMS - Now IQVIA

Triangle PEERS meets at IQVIA (formerly "Quintiles"), on the third Thursday of every month from 9:00 ‘til 11:00 AM, to discuss matters related to software quality assurance, software testing, clinical trial management, etc... All with an eye towards compliance with regulatory guidance from FDA, MHRA, and similar organizations.

Join your Triangle PEERS to discuss all-things 21CFR Part 11

Quintiles IMS - Now IQVIA

Triangle PEERS meets at IQVIA (formerly "Quintiles"), on the third Thursday of every month from 9:00 ‘til 11:00 AM, to discuss matters related to software quality assurance, software testing, clinical trial management, etc... All with an eye towards compliance with regulatory guidance from FDA, MHRA, and similar organizations.

Join your Triangle PEERS to discuss all-things 21CFR Part 11

Quintiles IMS - Now IQVIA

Triangle PEERS meets at IQVIA (formerly "Quintiles"), on the third Thursday of every month from 9:00 ‘til 11:00 AM, to discuss matters related to software quality assurance, software testing, clinical trial management, etc... All with an eye towards compliance with regulatory guidance from FDA, MHRA, and similar organizations.

Join your Triangle PEERS to discuss all-things 21CFR Part 11

Quintiles IMS - Now IQVIA

Triangle PEERS meets at IQVIA (formerly "Quintiles"), on the third Thursday of every month from 9:00 ‘til 11:00 AM, to discuss matters related to software quality assurance, software testing, clinical trial management, etc... All with an eye towards compliance with regulatory guidance from FDA, MHRA, and similar organizations.

Photos (2)